Skip to Content

Phreesia, Inc.

Securities Class Action

  • Date:
  • 7/13/2026
  • Company Name:
  • Phreesia, Inc.
  • Stock Symbol:
  • PHR
  • Class Period:
  • FROM 5/8/2025 TO 3/30/2026
  • Status:
  • Filed
  • Filing Date:
  • 5/13/2026
  • Court:
  • U.S. District Court: District of Delaware

Case Finder

Locate any case using the tools below.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE:PHR) in the United States District Court for the District of Delaware on behalf of all persons and entities who purchased or otherwise acquired Phreesia common stock between May 8, 2025, to March 30, 2026, both dates inclusive (the “Class Period”). Investors have until July 13, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

 

The complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose the true state of Phreesia’s slowing demand and reduced visibility in key revenue streams, notably, the weakened pharmaceutical marketing commitments in its Network Solutions segment.

 

On December 8, 2025, CFO Balaji Gandhi told investors on the Q3 2026 earnings call: "For fiscal year 2027, we expect revenue to be in the range of $545 million to $559 million." Gandhi also stated that the recently acquired AccessOne would "contribute approximately 6.5% of our fiscal 2027 total revenue outlook." On March 30, 2026, the Company issued its Q4 2026 earnings release and reduced FY 2027 revenue guidance to $510-$520 million -- a reduction of $35 million to $49 million from the prior range.

 

The Company attributed the revision to weaker pharmaceutical-marketing commitments and shorter visibility in its Network Solutions segment. Neither risk factor had been referenced in the December 8, 2025 earnings call, where management described "progress" in the selling season for network solutions. The stock fell 21-28% on the revised outlook.

 

If you purchased or otherwise acquired Phreesia shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, telephone at (212) 355-4648, or by filling out the form below.  There is no cost or obligation to you.
Contact Instructions
Please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com with any questions.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Phreesia. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: